Up a level |
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Weston, Jennifer, Dundar, Yenal, Nevitt, Sarah J ORCID: 0000-0001-9988-2709 and Marson, Anthony G ORCID: 0000-0002-6861-8806
(2020)
Antiepileptic drugs as prophylaxis for postcraniotomy seizures.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 4 (4).
CD007286-.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Weston, Jennifer, Dundar, Yenal, Nevitt, Sarah J ORCID: 0000-0001-9988-2709 and Marson, Anthony G ORCID: 0000-0002-6861-8806
(2018)
Antiepileptic drugs as prophylaxis for postcraniotomy seizures (Review).
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 5 (5).
CD007286-.
Aslam, RW ORCID: 0000-0002-0916-9641, Bates, V, Dundar, Yenal, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Dickson, Rumona ORCID: 0000-0003-1416-0913, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Fisher, Joanne et al (show 2 more authors)
(2016)
Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review.
Health Technology Assessment, 20 (77).
1-+.
Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dundar, Yenal, McEntee, Joanne and Syndikus, Isabel
(2020)
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 4 (4).
pp. 563-574.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus
(2018)
Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12).
[Report]
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Duarte, Rui, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Dundar, Yenal, McEntee, Joanne and Ahmad, Sajjad
(2019)
Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 3 (4).
pp. 453-461.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dickson, Rumona ORCID: 0000-0003-1416-0913, Dwan, Kerry, Richardson, Marty ORCID: 0000-0002-7097-8704, Dundar, Yenal, Davis, Helen and Banks, Lindsay
(2015)
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective.
PHARMACOECONOMICS, 33 (9).
pp. 893-904.
Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454, Dundar, Yenal, Kotas, Eleanor and McEntee, Joanne
(2021)
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 5 (1).
pp. 13-22.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Dwan, Kerry, Beale, Sophie ORCID: 0000-0003-0164-103X, Hockenhull, Juliet ORCID: 0000-0002-2026-3778, Proudlove, Christine, Dundar, Yenal, Richardson, Marty ORCID: 0000-0002-7097-8704, Dickson, Rumona ORCID: 0000-0003-1416-0913 et al (show 2 more authors)
(2015)
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
HEALTH TECHNOLOGY ASSESSMENT, 19 (47).
I-133.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria ORCID: 0000-0001-7211-5403, Vecchio, Fabio, Dundar, Yenal, Chaplin, Marty ORCID: 0000-0002-7097-8704 and Green, John A
(2021)
First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 3 (3).
CD010383-.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Dwan, Kerry, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria, Vecchio, Fabio, Dundar, Yenal, Jain, Pooja and Green, John A
(2016)
First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer.
Cochrane Database of Systematic Reviews, 2016 (5).
CD010383-.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Dundar, Yenal, Shah, Prakesh S and Shaw, Ben NJ
(2019)
Heated Humidified High-Flow Nasal Cannula for Preterm Infants: An Updated Systematic Review and Meta-analysis.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 35 (4).
pp. 298-306.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui et al (show 1 more authors)
(2020)
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.
HEALTH TECHNOLOGY ASSESSMENT, 24 (2).
1-+.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Lambe, Tosin, Nevitt, Sarah, Mahon, James, Boland, Angela, Beale, Sophie, Dundar, Yenal, Edwards, Katherine, Bresnahan, Rebecca, McEntee, Joanne et al (show 1 more authors)
(2020)
Midostaurin for treating advanced systemic mastocytosis [ID1573].
[Report]
Protogerou, Cleo, Fleernan, Nigel, Dwan, Kerry, Richardson, Marty ORCID: 0000-0002-7097-8704, Dundar, Yenal and Hagger, Martin S
(2015)
Moderators of the effect of psychological interventions on depression and anxiety in cardiac surgery patients: A systematic review and meta-analysis.
BEHAVIOUR RESEARCH AND THERAPY, 73.
pp. 151-164.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah, Bresnahan, Rebecca, Boland, Angela, Beale, Sophie, Lambe, Tosin, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 1 more authors)
(2021)
Nivolumab in combination with chemotherapy for untreated advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma [ID1465].
[Report]
Chaplin, Marty ORCID: 0000-0002-7097-8704, Bresnahan, Rebecca, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Houten, Rachel ORCID: 0000-0002-4315-7732, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley and Munot, Pinki
(2023)
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
PharmacoEconomics - Open, 7 (6).
pp. 863-875.
Bresnahan, Rebecca, Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 3 more authors)
(2023)
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PharmacoEconomics - open, 7 (4).
pp. 525-536.
Bresnahan, Rebecca, Houten, Rachel, Mahon, James, Beale, Sophie, Nevitt, Sarah, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne and Gandhi, Shreyans
(2021)
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria [ID3746].
[Report]
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Dickson, Rumona ORCID: 0000-0003-1416-0913, Proudlove, Chris and Dundar, Yenal
(2015)
Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer.
PHARMACOECONOMICS, 33 (1).
pp. 13-23.
Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Richardson, Marty ORCID: 0000-0002-7097-8704 and Dwan, Kerry
(2016)
Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 31 (4).
pp. 268-285.
Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Chaplin, Marty ORCID: 0000-0002-7097-8704, Edwards, Katherine, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley, Malik, Zafar et al (show 1 more authors)
(2023)
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 7 (3).
pp. 345-358.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Houten, Rachel, Edwards, Katherine, Donegan, Sarah, Boland, Angela, Beale, Sophie, Dundar, Yenal and Mcentee, Joanne
(2023)
Upadacitinib for treating moderately to severely active ulcerative colitis [ID3953].
[Report]
Nicholson, Amanda, Mahon, James, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Hockenhull, Juliet ORCID: 0000-0002-2026-3778 and Dundar, Yenal
(2015)
The clinical effectiveness and cost-effectiveness of the PROGENSA (R) prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.
Health Technology Assessment, 19 (87).
1-+.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Duarte, Rui and Shenoy, Aditya
(2019)
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine.
BMC CANCER, 19 (1).
1209-.
Aslam, Rabeea'h W ORCID: 0000-0002-0916-9641, Bates, Vickie, Dundar, Yenal, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Dickson, Rumona ORCID: 0000-0003-1416-0913, Boland, Angela ORCID: 0000-0002-5435-8644, Fisher, Joanne, Robinson, Louise et al (show 1 more authors)
(2018)
A systematic review of the diagnostic accuracy of automated tests for cognitive impairment.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 33 (4).
pp. 561-575.
Ghattaoraya, Gurpreet S ORCID: 0000-0003-4809-7342, Dundar, Yenal ORCID: 0000-0002-9847-1622, González-Galarza, Faviel F, Maia, Maria Helena Thomaz, Santos, Eduardo José Melo, da Silva, Andréa Luciana Soares, McCabe, Antony ORCID: 0000-0003-3089-3674, Middleton, Derek, Alfirevic, Ana ORCID: 0000-0002-2801-9817, Dickson, Rumona ORCID: 0000-0003-1416-0913 et al (show 1 more authors)
(2016)
A web resource for mining HLA associations with adverse drug reactions: HLA-ADR.
Database : the journal of biological databases and curation, 2016.
baw069-.